PTEN Loss and PD-L1 Expression of Different Histological Patterns of Prostate Cancer

dc.authorid0000-0002-5046-7536
dc.contributor.authorKır, Gözde
dc.contributor.authorCecikoglu, Gozde Ecem
dc.contributor.authorOlgun, Zeynep Çağla
dc.contributor.authorKazan, Huseyin Ozgur
dc.contributor.authorYıldırım, Asıf
dc.date.accessioned2025-05-10T19:43:27Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractAims: Although several studies have evaluated PTEN loss in Prostatic Adenocarcinoma (PCa), PTEN loss correlation with different histological patterns only has a few studies. Although several studies have evaluated PD-L1 expression in PCa and its correlation with Gleason scores, as far as we know, there are no prior studies that have included a comparison between PD-L1 expression and histological patterns of PCa. This study aims to evaluate PTEN loss and PD-L1 expression by immunohistochemistry in different histological patterns of PCa. Methods: The current study included consecutive 98 radical prostatectomy specimens with 151 foci with different Gleason Grade (GG) patterns. Results: The highest frequency of PTEN loss was observed in GG4 cribriform and glomeruloid patterns (59.3%, p < 0.001). Combined score (CS) PD-L1 positivity was observed in fourteen patients (14.2%). Tumor cell (TC) and tumor-associated inflammatory cells (IC) PD-L1 positivity was observed in 10 (10.2%) and 7 (7.1%) patients. The highest frequency of PD-L1 expression was observed in the GG5 pattern, and between GG4 patterns, the irregular pattern had the highest PD-L1 positivity. Conclusions: In conclusion, in our cohort of consecutive unselected cases of prostatic carcinoma, we observed the highest PTEN loss rate in the GG4 cribriform and glomeruloid pattern and the highest PD-L1 expression rate in the GG5 and GG4 irregular patterns. These results may predict molecular differences between different histological patterns in PCa and may be used to inform a treatment decision. Future studies should investigate these differences between histological patterns of PCa to predict response to immunotherapy in larger cohorts.
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK), Turkey [120S758]
dc.description.sponsorshipThis study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK), Turkey (Project Number: 120S758).
dc.identifier.doi10.1016/j.prp.2021.153738
dc.identifier.issn0344-0338
dc.identifier.issn1618-0631
dc.identifier.pmid34922209
dc.identifier.scopus2-s2.0-85121220206
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.prp.2021.153738
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10604
dc.identifier.volume229
dc.identifier.wosWOS:000735375800001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Gmbh
dc.relation.ispartofPathology Research and Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectProstate cancer
dc.subjectPTEN
dc.subjectPD-L1
dc.subjectArchitectural pattern
dc.subjectCribriform pattern
dc.titlePTEN Loss and PD-L1 Expression of Different Histological Patterns of Prostate Cancer
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
10604.pdf
Boyut:
3.71 MB
Biçim:
Adobe Portable Document Format